NTLA LAWSUIT ALERT: Levi & Korsinsky Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline — Neutral
NTLA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129319&wire=1 or contact Joseph E. Levi, Esq.
Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN — Neutral
AZN Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129328&wire=1 or contact Joseph E. Levi, Esq.
Lost Money on FTAI Aviation Ltd. (FTAI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
FTAI Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129331&wire=1 or contact Joseph E.
Mullen Automotive Inc. Announces Reverse Stock Split Effective Feb. 18, 2025 — Neutral
MULN GlobeNewsWire — February 13, 2025BREA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announced today that it will effect a 1-for-60 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on Feb. 18, 2025, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the existing symbol MULN and will begin trading on a split-adjusted basis when the market opens on Feb. 18, 2025. The new CUSIP …
Shareholders that Lost Money on Caribou Biosciences, Inc. (CRBU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
CRBU Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=129333&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc. (NMRA) — Neutral
NMRA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129306&wire=1 or contact Joseph E. Levi, Esq.
Nextracker Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 25, 2025 to Discuss Your Rights - NXT — Neutral
NXT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129326&wire=1 or contact Joseph E. Levi, Esq.
Harmonic Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HLIT — Neutral
HLIT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.
Pacira BioSciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX — Neutral
PCRX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129330&wire=1 or contact Joseph E. Levi, Esq.
Investors Who Lost Money on Regeneron Pharmaceuticals, Inc. (REGN) Should Contact Levi & Korsinsky About Pending Class Action - REGN — Neutral
REGN Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=129320&wire=1 or contact Joseph E. Levi, Esq.
February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - RIG — Neutral
RIG Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129321&wire=1 or contact Joseph E.
Johnson & Johnson halts late-stage E.coli vaccine trial after poor results — Negative
JNJ New York Post — February 13, 2025Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.
Gilat's Q4 Earnings Surpass Estimates, Revenues Lag, Stock Tanks — Positive
GILT Zacks Investment Research — February 13, 2025GILT's fourth-quarter 2024 performance reflects expanding momentum in the defense and IFC sectors, backed by increasing deal wins.
Verizon Wins Multiple 5G Network Awards: VZ Stock to Benefit? — Neutral
VZ Zacks Investment Research — February 13, 2025VZ appears to be treading in the middle of the road and investors could be better off if they trade with caution.
CrowdStrike Rallies 27% YTD: Should You Buy the Stock or Book Profit? — Positive
CRWD Zacks Investment Research — February 13, 2025With robust financial performance, continued innovation and market leadership, CrowdStrike remains a compelling investment option right now.
Quantum's Q3 Loss Wider Than Expected, Revenues Increase Y/Y — Positive
QMCO Zacks Investment Research — February 13, 2025QMCO Q3 revenues beat expectations while earnings miss. Top and bottom lines improve year over year, driven by its business transformation and efficiency efforts.
Best Momentum Stocks to Buy for February 13th — Positive
NTRS VCYT Zacks Investment Research — February 13, 2025VCYT and NTRS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2025.
Hertz Global (HTZ) Reports Q4 Earnings: What Key Metrics Have to Say — Neutral
HTZ Zacks Investment Research — February 13, 2025While the top- and bottom-line numbers for Hertz Global (HTZ) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hyatt Hotels (H) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
H Zacks Investment Research — February 13, 2025The headline numbers for Hyatt Hotels (H) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Iron Mountain Incorporated (IRM) Q4 2024 Earnings Call Transcript — Neutral
IRM Seeking Alpha — February 13, 2025Iron Mountain Incorporated (NYSE:IRM ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Mark Rupe - Senior Vice President of Investor Relations William Meaney - President and Chief Executive Officer Barry Hytinen - Executive Vice President and Chief Financial Officer Conference Call Participants George Tong - Goldman Sachs Nathan Crossett - BNP Eric Luebchow - Wells Fargo Brendan Lynch - Barclays Kevin McVeigh - UBS Andrew Steinerman - JPMorgan Shlomo Rosenbaum - Stifel Jonathan Atkin - RBC Capital Markets Operator Good morning and welcome to the Iron Mountain Fourth Quarter 2024 Earnings Conference Call. All …
